Table of Contents

2019 Month : June Volume : 8 Issue : 23 Page : 1830-1833

STUDY OF PREVALENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE AND ITS ASSOCIATION WITH TYPE 2 DIABETES MELLITUS IN A TERTIARY CARE HOSPITAL.

Ramya Bhat S1, Indumathi Shankaraiah2

1Assistant Professor, Department of Medicine, Subbaiah Medical College, Shivamogga, Karnataka, India.
2Assistant Professor, Department of Medicine, Subbaiah Medical College, Shivamogga, Karnataka, India.

References :

1

Reid AE. Non-alcoholic fatty liver disease. In: Feldman M, Frieddman LS, Brandt LJ, eds. Sleisenger and Fordtran’s Gastrointestinal and Liver disease. 9th edn. Philadelphia: 2010: p. 1401-11.

2

Dowman JK, Tomlinson JW, Newsome PN. Pathogenesis of non-alcoholic fatty liver disease. Q J Med 2010;103(2):71-83.        

CrossRef | Google Scholar | PubMed
3

Caldwell SH, Argo CK. Non-alcoholic fatty liver disease and nutrition. In: Dooley JS, Lok ASF, Burroughs AK, et al. eds. Sherlock’s Diseases of the liver and biliary system. 12th edn. West Sussex 2011: p. 546-62.

4

Chawla YK, Taneja S. Non-Alcoholic fatty liver disease. In: Munjal YP, Sharma SK, eds. API Textbook of Medicine 9th edn. Mumbai: 2012: p. 885-7.

5

Bacon BR. Genetic, Metabolic and infiltrative diseases affecting the liver. In: Fauci, Braunwald, Kasper, eds. Harrison’s Principles of internal medicine. 18th edn. New York: McGraw-Hill Publications 2012: p. 2603-5.

6

Day CP, James OF. Steatohepatitis: a tale of two ‘hits’? Gastroenterology 1998;114(4):842-5.        

Google Scholar | PubMed
7

Jou J, Choi SS, Diehl AM. Mechanisms of disease progression in non-alcoholic fatty liver disease. Semin Liver Dis 2008;28(4):370-9.             

CrossRef | Google Scholar | PubMed
8

Roskams T, Yang SQ, Koteish A, et al. Oxidative stress and oval cell accumulation in mice and humans with alcoholic and non-alcoholic fatty liver disease. Am J Pathol 2003;163(4):1301-11.   

CrossRef | Google Scholar | PubMed
9

Mantzoros CS. The role of leptin in human obesity and disease: a review of current evidence. Ann Intern Med 1999;130(8):671-80.      

CrossRef | Google Scholar | PubMed
10

Younossi ZM. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Alimentary Pharmacology & Therapeutics 2008;28(1):2-12.                   

CrossRef | Google Scholar | PubMed
11

Huang XD, Fan Y, Zhang H, et al. Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. World J Gastroenterol 2008;14(18):2888-93.       

CrossRef | Google Scholar | PubMed
12

Uygun A, Kadayifci A, Yesilova Z, et al. Serum leptin levels patients with non-alcoholic steatohepatitis. Am J Gastroenterol 2000;95(12):3584-9.       

CrossRef | Google Scholar | PubMed
13

Targher G, Bertolini L, Padovani R, et al. Prevalence of non-alcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007;30(5):1212-8.           

CrossRef | Google Scholar | PubMed
14

Agarwal AK, Jain V, Singla S, et al. Prevalence of non-alcoholic fatty liver disease and its correlation with coronary risk factors in patients with type 2 diabetes. J Assoc Physicians India 2011;59:351-4. 

Google Scholar | PubMed
15

Bedogni G, Miglioli L, Masutti F, et al. Prevalence of and risk factors for non-alcoholic fatty liver disease: the Dionysos Nutrition and Liver Study. Hepatology 2005;42(1):44-52.               

CrossRef | Google Scholar | PubMed